The ATOM Molecular Design Approach for Accelerated Drug Discovery
During the May Accelerating Therapeutics for Opportunities in Medicine (ATOM) Webinar Series, discover how computing and machine learning can accelerate molecular optimization for cancer and infectious disease therapeutics.
The ATOM Consortium is a public-private partnership whose mission is to transform drug discovery by accelerating the development of more effective therapies for patients.
This webinar will demonstrate how ATOM strives to:
- speed up molecular optimization for applications ranging from cancer to infectious disease therapeutics with the help of computing and machine learning,
- establish multiparameter property optimization across efficacy, safety, pharmacokinetics, and developability, and
- develop systems with the potential to guide and optimize experimental data collection and design validation.
Mr. Brase is the deputy associate director for computing at Lawrence Livermore National Laboratory (LLNL). He leads LLNL research in the application of high-performance computing, large-scale data science, and simulation to a broad range of national security and science missions. Mr. Brase is also co-lead of the ATOM Consortium for computational acceleration of drug discovery and on the leadership team of the COVID-19 HPC Consortium. His research interests focus on the intersection of machine learning, simulation, and high-performance computing. He is currently leading efforts on large-scale computing for life science, biosecurity, and nuclear security applications.
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024